Meeting
2023 ASCO Genitourinary Cancers Symposium
Testicular radiomics correlated with pathology at time of post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumor.
Authors
Jacob Taylor
UTSW Medical Center, Dallas, TX
Jacob Taylor , Nikit Venishetty , Yin Xi , Jeffrey Howard , Yee Seng Ng , Aditya Bagrodia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 413)
DOI
10.1200/JCO.2023.41.6_suppl.413
Abstract #
413
Poster Bd #
L15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
A novel radiomics-miRNAs integrated model to predict the histopathology of residual retroperitoneal masses in metastatic nonseminomatous germ cell tumors.
First Author: Xiangdong Li
Poster
2020 Genitourinary Cancers Symposium
Surveillance of postchemotherapy subcentimeter residual retroperitoneal mass (RRM) in metastatic nonseminomatous germ cell tumor (mNSGCT).
First Author: Cody Cotner
Poster
2017 ASCO Annual Meeting
Applying radiomics to predict pathology of post chemotherapy retroperitoneal nodal masses in germ cell tumors (GCT).
First Author: Jeremy Howard Lewin
First Author: Suliman Boulos